Download PDF
Int J Angiol 2015; 24(02): 099-104
DOI: 10.1055/s-0034-1396948
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Percutaneous Transcatheter Closure of Ruptured Sinus of Valsalva Aneurysm: Immediate Result and Long-Term Follow-Up

Sudhir Chandra Sinha
1   Department of Cardiology, Indus Hospitals, Visakhapatnam, India
,
Vipperla Sujatha
1   Department of Cardiology, Indus Hospitals, Visakhapatnam, India
,
Anil Kumar Mahapatro
1   Department of Cardiology, Indus Hospitals, Visakhapatnam, India
› Author Affiliations
Further Information

Publication History

Publication Date:
14 January 2015 (online)

    Permissions and Reprints

Abstract

There is scarcity of data on closure and long-term follow-up of percutaneous treatment of ruptured sinus of Valsalva aneurysm (RSOVA). In this article, we present our experience in percutaneous closure of this defect. Between December 2009 and July 2014, 11 cases of RSOVA were referred to our hospital. Eight of the 11 cases (72.7%) were considered for percutaneous closure. Seven of the eight (87.5%) patients underwent successful percutaneous closure. There were four females and three males in the age group of 16 to 48 years (mean 24.7 ± 6.1 years). Associated defects were bicuspid aortic valve in one patient, mild preexisting aortic regurgitation in two patients, and healed infective endocarditis in one patient. Echocardiography revealed RSOVA from right coronary sinus (RCS) to right atrium (RA) in one patient (14.3%), RCS to right ventricular outflow in three patients (42.8%), and noncoronary sinus ruptured into RA in three patients (42.8%). All patients were symptomatic in New York Heart Association (NYHA) class II to IV. The defect size ranged from 7 to 10 mm (mean 8.4 ± 1.3 mm). The defects were closed from the venous side with device selection 2 to 4 mm higher than the defect size under fluoroscopy and transesophageal echocardiography guidance. Technical success was 87.5%. The mean device size was 12.0 ± 1.6 mm/10.0 ± 1.6 mm. Six out of seven patients (85.7%) had complete disappearance of shunt before discharge. During 1 to 55 months follow-up, all patients were in NYHA class I. There was no residual shunt, progression of AR or new AR, infective endocarditis or device embolization. Percutaneous closure of RSOVA appears to be a safe alternative to surgical therapy, with high technical success and excellent long-term outcome.

Keywords

aneurysm - cardiac catheterization - cardiac device - endocarditis - endovascular procedure - percutaneous - cardiac surgery
 

  • References

  • 1 Kirklin JW, Barratt-Boyes BG. Congenital sinus of Valsalva aneurysm and aortic left ventricular tunnel. In: Kirklin JW, Barratt-Boyes BG, , eds. Cardiac Surgery. 3rd ed. New York: Churchill-Livingstone; 2003: 911-927
    Google Scholar
  • 2 Edwards JE, Burchell HB. The pathological anatomy of deficiencies between the aortic root and the heart, including aortic sinus aneurysms. Thorax 1957; 12 (2) 125-139
    CrossrefPubMedGoogle Scholar
  • 3 Fishbein MC, Obma R, Roberts WC. Unruptured sinus of Valsalva aneurysm. Am J Cardiol 1975; 35 (6) 918-922
    CrossrefPubMedGoogle Scholar
  • 4 Sakakibara S, Konno S. Congenital aneurysm of the sinus of Valsalva. Anatomy and classification. Am Heart J 1962; 63: 405-424
    CrossrefPubMedGoogle Scholar
  • 5 Sakakibara S, Konno S. Congenital aneurysms of sinus of Valsalva. A clinical study. Am Heart J 1962; 63: 708-719
    CrossrefPubMedGoogle Scholar
  • 6 Arora R, Trehan V, Rangasetty UM, Mukhopadhyay S, Thakur AK, Kalra GS. Transcatheter closure of ruptured sinus of Valsalva aneurysm. J Interv Cardiol 2004; 17 (1) 53-58
    CrossrefPubMedGoogle Scholar
  • 7 Cullen S, Somerville J, Redington A. Transcatheter closure of a ruptured aneurysm of the sinus of Valsalva. Br Heart J 1994; 71 (5) 479-480
    CrossrefPubMedGoogle Scholar
  • 8 Amplatz K, Moller JH. Radiology of Congenital Heart Disease. Mosby Yearbook, St Louis 1993 (2nd ed.), Vol I, Chapter 24, 395–406.
    Google Scholar
  • 9 Kerkar PG, Lanjewar CP, Mishra N, Nyayadhish P, Mammen I. Transcatheter closure of ruptured sinus of Valsalva aneurysm using the Amplatzer duct occluder: immediate results and mid-term follow-up. Eur Heart J 2010; 31 (23) 2881-2887
    CrossrefPubMedGoogle Scholar
  • 10 Guan L, Zhou D, Zhang F , et al. Percutaneous device closure of ruptured sinus of Valsalva aneurysm: a preliminary experience. J Invasive Cardiol 2013; 25 (10) 492-496
    PubMedGoogle Scholar
  • 11 Radhakrishnan S. Awasthy Neeraj. Transcatheter device closure of ruptured sinus of Valsalva: not addressing the pathology, does it make a difference? TCT-680. J Am Coll Cardiol 2013; 62 (18) 208 (poster abstracts TCT-680 in TCT 2013)
    CrossrefPubMedGoogle Scholar
  • 12 Rao PS, Bromberg BI, Jureidini SB, Fiore AC. Transcatheter occlusion of ruptured sinus of Valsalva aneurysm: innovative use of available technology. Catheter Cardiovasc Interv 2003; 58 (1) 130-134
    CrossrefPubMedGoogle Scholar
  • 13 Chang CW, Chiu SN, Wu ET, Tsai SK, Wu MH, Wang JK. Transcatheter closure of a ruptured sinus of Valsalva aneurysm. Circ J 2006; 70 (8) 1043-1047
    CrossrefPubMedGoogle Scholar
  • 14 Zhao SH, Yan CW, Zhu XY , et al. Transcatheter occlusion of the ruptured sinus of Valsalva aneurysm with an Amplatzer duct occluder. Int J Cardiol 2008; 129 (1) 81-85
    CrossrefPubMedGoogle Scholar
  • 15 Sen S, Chattopadhyay A, Ray M, Bandyopadhyay B. Transcatheter device closure of ruptured sinus of Valsalva: immediate results and short term follow up. Ann Pediatr Cardiol 2009; 2 (1) 79-82
    CrossrefPubMedGoogle Scholar
  • 16 Szkutnik M, Kusa J, Glowacki J, Fiszer R, Bialkowski J. Transcatheter closure of ruptured sinus of Valsalva aneurysms with an Amplatzer occluder. Rev Esp Cardiol 2009; 62 (11) 1317-1321
    CrossrefPubMedGoogle Scholar